Cargando…
Detection of the DCC gene product in normal and malignant colorectal tissues and its relation to a codon 201 mutation.
Protein expression of the putative tumour-suppressor gene DCC on chromosome 18q was evaluated in a panel of 16 matched colorectal cancer and normal colonic tissue samples together with DCC mRNA expression and allelic deletions (loss of heterozygosity, LOH). Determined by a polymerase chain reaction...
Autores principales: | Schmitt, C. A., Thaler, K. R., Wittig, B. M., Kaulen, H., Meyer zum Büschenfelde, K. H., Dippold, W. G. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2149930/ https://www.ncbi.nlm.nih.gov/pubmed/9484816 |
Ejemplares similares
-
The role of the Thomsen-Friedenreich antigen as a tumor-associated molecule.
por: Dippold, W, et al.
Publicado: (1990) -
Reduced expression of deleted colorectal carcinoma (DCC) protein in established colon cancers.
por: Goi, T., et al.
Publicado: (1998) -
Present Status and Future of DCC Analysis
por: Nayak, Tapank K., et al.
Publicado: (1998) -
Defining the Ligand Specificity of the Deleted in Colorectal Cancer (DCC) Receptor
por: Haddick, Patrick C. G., et al.
Publicado: (2014) -
Differentiation of malignant from benign pancreatic mass by Tl-201 abdominal SPECT.
por: Bom, H. S., et al.
Publicado: (1995)